✉ info@591daili.com☎ +86-18553102138
📞 WhatsAppEnglish
591daili 济南圣和化工
首页 › 产品目录 › 吉美拉西尔

吉美拉西尔

CAS 103766-25-2C5H4ClNO2MW 145.54

吉美拉西尔,CAS 登记号 103766-25-2,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于有机化学品。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。

规格参数

CAS号103766-25-2
分子式C5H4ClNO2
分子量145.54
LogP-0.1
纯度按批次COA提供(不公开发布)
包装按订单/批次确认(不公开发布)
应用领域有机化学品
类别有机化学品

用途与场景

有机化学品

包装与供货

包装规格按订单/批次确认(不公开发布)
纯度规格按批次COA提供(不公开发布)
储存条件密封、阴凉干燥处保存
供货周期现货/按订单安排

文件与支持

每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。

常见问题

在哪里能查到 吉美拉西尔 的 CAS 号?

本页已列出 吉美拉西尔 的 CAS 号:103766-25-2,可与随货 COA 核对。

可以提供哪些规格和包装?

常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。

吉美拉西尔 一般用在什么产品里?

主要涉及有机化学品。

下单流程是怎样的?

来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。

PubChem 公开数据

Description

GIMERACIL · CAS 103766-25-2 · C5H4ClNO2. UNII UA8SE1325T.

Identification

CAS Registry Number103766-25-2
PubChem CID54679224
Molecular formulaC5H4ClNO2
IUPAC name5-chloro-4-hydroxy-1H-pyridin-2-one
UNII (FDA)UA8SE1325T

Computed Descriptors

Molecular Weight145.54
XLogP3-0.1
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count2
Rotatable Bond Count0
Exact Mass144.9930561
Monoisotopic Mass144.9930561
Topological Polar Surface Area49.3
Heavy Atom Count9
Formal Charge0

GHS Hazard Classification

Reported hazard statementsH302 (100%), H315 (50%), H319 (50%), H335 (50%)

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

H315 (50%): Causes skin irritation [Warning Skin corrosion/irritation]

Documented Uses

  • Gimeracil is used as an adjunct to antineoplastic therapy. When used within the product Teysuno, gimeracil is indicated for the treatment of adults with advanced gastric (stomach) cancer when given in combination with cisplatin.
  • Drink plenty of fluids. Drinking water is important to prevent dehydration when taking Teysuno.
  • Take on an empty stomach. Take Teysuno at least 1 hour before or after eating.
  • Following a single dose of Teysuno, approximately 3.8% to 4.2% of administered tegafur, 65% to 72% of administered gimeracil, and 3.5% to 3.9% of administered oteracil were excreted unchanged in the urine.
  • Although no intravenous data are available for Teysuno in humans, the volume of distribution could be roughly estimated from the apparent volume of distribution and urinary excretion data as 16 l/m2, 17 l/m2, and 23 l/m2 for tegafur, gimeracil and oteracil, respectively.
  • Oteracil, gimeracil, 5-FU, and tegafur are 8.4%, 32.2%, 18.4%, and 52.3% protein bound, respectively.

Synonyms

Gimeracil; 103766-25-2; 5-Chloro-2,4-dihydroxypyridine; gimestat; 5-Chloro-2,4-pyridinediol; DTXSID8046799; Gimeracilo; UA8SE1325T; DTXCID6026799; TEYSUNO COMPONENT GIMERACIL; CDHP; gimeracilum; Chlorodihydroxypyridine; RefChem:639937; 5-chloropyridine-2,4-diol; 5-Chloro-4-hydroxy-1H-pyridin-2-one

Frequently Asked Questions

What are the CAS number and molecular formula of GIMERACIL?

CAS 103766-25-2; molecular formula C5H4ClNO2; molecular weight — g/mol.

What other names is GIMERACIL known by?

Gimeracil, 103766-25-2, 5-Chloro-2,4-dihydroxypyridine, gimestat, 5-Chloro-2,4-pyridinediol, DTXSID8046799.

Is GIMERACIL classified as hazardous?

Hazard statements reported: H302, H315, H319, H335.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.

同类推荐

获取 吉美拉西尔 报价

供应商:济南圣和化工有限公司 · 一个工作日内回复。

邮件询价 WhatsApp
鲁ICP备19031700号-1